These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25819874)

  • 1. Does in utero exposure of antiepileptic drugs lead to failure to reach full cognitive potential?
    McCorry D; Bromley R
    Seizure; 2015 May; 28():51-6. PubMed ID: 25819874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
    Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
    Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
    Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol.
    Stjerna S; Huber-Mollema Y; Tomson T; Perucca E; Battino D; Craig J; Sabers A; Thomas S; Vajda F; Gaily E
    Epilepsy Behav; 2024 Oct; 159():110024. PubMed ID: 39217754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
    Meador KJ; Baker GA; Browning N; Clayton-Smith J; Combs-Cantrell DT; Cohen M; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    N Engl J Med; 2009 Apr; 360(16):1597-605. PubMed ID: 19369666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal antiepileptic drug exposure and cognitive outcomes.
    Bromley RL; Baker GA
    Seizure; 2017 Jan; 44():225-231. PubMed ID: 27784632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common antiepileptic drugs in pregnancy in women with epilepsy.
    Adab N; Tudur SC; Vinten J; Williamson P; Winterbottom J
    Cochrane Database Syst Rev; 2004; (3):CD004848. PubMed ID: 15266543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    JAMA Pediatr; 2014 Aug; 168(8):729-36. PubMed ID: 24934501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.
    Bromley RL; Baker GA; Meador KJ
    Curr Opin Neurol; 2009 Apr; 22(2):162-6. PubMed ID: 19532040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child development following in utero exposure: levetiracetam vs sodium valproate.
    Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ;
    Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies.
    Banach R; Boskovic R; Einarson T; Koren G
    Drug Saf; 2010 Jan; 33(1):73-9. PubMed ID: 20000869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Lancet Neurol; 2013 Mar; 12(3):244-52. PubMed ID: 23352199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobehavioral consequences of prenatal antiepileptic drug exposure.
    Nadebaum C; Anderson V; Vajda F; Reutens D; Wood A
    Dev Neuropsychol; 2012; 37(1):1-29. PubMed ID: 22292829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.
    Cummings C; Stewart M; Stevenson M; Morrow J; Nelson J
    Arch Dis Child; 2011 Jul; 96(7):643-7. PubMed ID: 21415043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longer term outcome of children born to mothers with epilepsy.
    Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
    Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
    Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.
    Veiby G; Daltveit AK; Schjølberg S; Stoltenberg C; Øyen AS; Vollset SE; Engelsen BA; Gilhus NE
    Epilepsia; 2013 Aug; 54(8):1462-72. PubMed ID: 23865818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral characteristics and cognitive development among school age children born to women with epilepsy.
    Güveli BT; Gürses C; Ataklı D; Akça Kalem Ş; Dirican A; Bebek N; Baykan B; Gökyiğit A
    Neurol Res; 2015 Apr; 37(4):295-300. PubMed ID: 25310353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Brain; 2011 Feb; 134(Pt 2):396-404. PubMed ID: 21224309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.